Trends in inflammatory bowel disease therapy.
Thomson
A B
AB
University of Alberta, Department of Medicine, Edmonton. alan.thomson@ualberta.ca
Williams
C N
CN
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D003424:Crohn Disease / Q000188:drug therapy / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D006801:Humans; D019804:Mesalamine / Q000627:therapeutic use; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine